Stock listing
Frankfurt:XUP Genfit SA Aktie
German listing (Frankfurt) of Genfit SA · home listing Euronext:GNFT
Follow Genfit SA into a list and get an email when it puts out news.
Share price · FWB:XUP
€10.44 EUR -0.14 (-1.3%)
Close on Nov 17, 2026
- Day range
- €10.44 – €10.44 EURNov 17, 2026
- Market cap
- €522.3M EURAt the close on Nov 17, 2026 · price × 50.03M shares outstanding
- 52-week range
- €3.64 – €14.75 EURLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
- Traded on an average day
- €37,325 EURMedian day 0 shares · 49 days with no trades · last 3 months, Aug 17, 2026 – Nov 13, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:GNFT · Home | €10.22 EUR | -0.34 (-3.2%) | 155,867 | €10.38 | €10.42 | €10.12 | €10.56 | Close on Nov 17, 2026 |
| OTC:GNFTF | $9.43 USD | 0.00 (0.0%) | — | $9.43 | $9.43 | $9.43 | $9.43 | Close on Nov 6, 2026 |
| Frankfurt:XUP | €10.44 EUR | -0.14 (-1.3%) | — | €10.44 | €10.44 | €10.44 | €10.58 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 13, 2026 · FWB:XUP · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €10.65 | -0.157 | -1.5% | €10.65 | €10.65 | €10.65 | 0 | |
| €10.81 | +0.225 | +2.1% | €10.81 | €10.81 | €10.81 | 0 | |
| €10.59 | -0.414 | -3.8% | €10.59 | €10.59 | €10.59 | 5,238 | |
| €11.00 | +0.343 | +3.2% | €11.00 | €11.00 | €11.00 | 67,124 | |
| €10.66 | -0.535 | -4.8% | €10.66 | €10.66 | €10.66 | 0 | |
| €11.19 | +0.20 | +1.8% | €11.19 | €11.19 | €11.19 | 1,406 | |
| €10.99 | -0.09 | -0.8% | €10.99 | €10.99 | €10.99 | 0 | |
| €11.08 | +0.907 | +8.9% | €11.08 | €11.08 | €11.08 | 84,080 | |
| €10.18 | -0.63 | -5.8% | €10.18 | €10.18 | €10.18 | 0 | |
| €10.81 | -0.437 | -3.9% | €10.81 | €10.81 | €10.81 | 0 | |
| €11.24 | -0.172 | -1.5% | €11.24 | €11.24 | €11.24 | 1,598 | |
| €11.41 | +1.088 | +10.5% | €11.41 | €11.41 | €11.41 | 438 | |
| €10.33 | +1.716 | +19.9% | €10.33 | €10.33 | €10.33 | 2,854 | |
| €8.61 | +0.038 | +0.4% | €8.61 | €8.61 | €8.61 | 0 | |
| €8.572 | -0.251 | -2.8% | €8.572 | €8.572 | €8.572 | 344 | |
| €8.823 | -0.278 | -3.1% | €8.823 | €8.823 | €8.823 | 0 | |
| €9.101 | +0.23 | +2.6% | €9.101 | €9.101 | €9.101 | 0 | |
| €8.871 | +0.592 | +7.2% | €8.871 | €8.871 | €8.871 | 0 | |
| €8.279 | -0.007 | -0.1% | €8.279 | €8.279 | €8.279 | 0 | |
| €8.286 | +0.194 | +2.4% | €8.286 | €8.286 | €8.286 | 0 | |
| €8.092 | +0.363 | +4.7% | €8.092 | €8.092 | €8.092 | 0 | |
| €7.729 | -0.102 | -1.3% | €7.729 | €7.729 | €7.729 | 0 | |
| €7.831 | -0.50 | -6.0% | €7.831 | €7.831 | €7.831 | 0 | |
| €8.331 | +0.112 | +1.4% | €8.331 | €8.331 | €8.331 | 0 | |
| €8.219 | -0.094 | -1.1% | €8.219 | €8.219 | €8.219 | 0 | |
| €8.313 | -0.712 | -7.9% | €8.313 | €8.313 | €8.313 | 602 | |
| €9.025 | -0.206 | -2.2% | €9.025 | €9.025 | €9.025 | 64,578 | |
| €9.231 | +0.173 | +1.9% | €9.231 | €9.231 | €9.231 | 0 | |
| €9.058 | +0.162 | +1.8% | €9.058 | €9.058 | €9.058 | 0 | |
| €8.896 | -0.433 | -4.6% | €8.896 | €8.896 | €8.896 | 0 | |
| €9.329 | -0.53 | -5.4% | €9.329 | €9.329 | €9.329 | 338 | |
| €9.859 | -0.009 | -0.1% | €9.859 | €9.859 | €9.859 | 0 | |
| €9.868 | +0.223 | +2.3% | €9.418 | €9.89 | €9.342 | 1,990 | |
| €9.645 | -0.334 | -3.3% | €9.645 | €9.645 | €9.645 | 0 | |
| €9.979 | +1.037 | +11.6% | €8.683 | €10.04 | €8.667 | 500 | |
| €8.942 | -1.077 | -10.7% | €8.942 | €8.942 | €8.942 | 968 | |
| €10.02 | -0.338 | -3.3% | €10.02 | €10.02 | €10.02 | 0 | |
| €10.36 | -0.394 | -3.7% | €10.36 | €10.36 | €10.36 | 0 | |
| €10.75 | -0.715 | -6.2% | €10.75 | €10.75 | €10.75 | 0 | |
| €11.47 | -0.171 | -1.5% | €11.47 | €11.47 | €11.47 | 0 | |
| €11.64 | -0.214 | -1.8% | €11.64 | €11.64 | €11.64 | 0 | |
| €11.85 | +0.244 | +2.1% | €11.85 | €11.85 | €11.85 | 0 | |
| €11.61 | -0.966 | -7.7% | €11.61 | €11.61 | €11.61 | 0 | |
| €12.57 | -0.315 | -2.4% | €12.57 | €12.57 | €12.57 | 0 | |
| €12.89 | -0.847 | -6.2% | €12.89 | €12.89 | €12.89 | 0 | |
| €13.74 | +1.799 | +15.1% | €13.63 | €13.85 | €13.47 | 200 | |
| €11.94 | -1.136 | -8.7% | €11.94 | €11.94 | €11.94 | 200 | |
| €13.07 | -0.312 | -2.3% | €13.07 | €13.07 | €13.07 | 0 | |
| €13.38 | -0.297 | -2.2% | €13.38 | €13.38 | €13.38 | 0 | |
| €13.68 | -0.068 | -0.5% | €13.68 | €13.68 | €13.68 | 0 | |
| €13.75 | -0.439 | -3.1% | €13.75 | €13.75 | €13.75 | 0 | |
| €14.19 | +0.246 | +1.8% | €14.19 | €14.19 | €14.19 | 0 | |
| €13.94 | -0.095 | -0.7% | €13.94 | €13.94 | €13.94 | 0 | |
| €14.04 | -0.177 | -1.2% | €14.04 | €14.04 | €14.04 | 0 | |
| €14.21 | -0.278 | -1.9% | €14.21 | €14.21 | €14.21 | 0 | |
| €14.49 | +0.219 | +1.5% | €14.49 | €14.49 | €14.49 | 0 | |
| €14.27 | +0.112 | +0.8% | €14.27 | €14.27 | €14.27 | 0 | |
| €14.16 | +0.374 | +2.7% | €14.16 | €14.16 | €14.16 | 0 | |
| €13.79 | -0.404 | -2.8% | €13.79 | €13.79 | €13.79 | 0 | |
| €14.19 | +0.145 | +1.0% | €14.19 | €14.19 | €14.19 | 0 | |
| €14.05 | -0.241 | -1.7% | €14.05 | €14.05 | €14.05 | 0 | |
| €14.29 | +0.663 | +4.9% | €14.29 | €14.29 | €14.29 | 0 | |
| €13.62 | -0.106 | -0.8% | €13.62 | €13.62 | €13.62 | 0 | |
| €13.73 | +0.838 | +6.5% | €13.73 | €13.73 | €13.73 | 0 | |
| €12.89 | -0.312 | -2.4% | €12.89 | €12.89 | €12.89 | 0 |
- Ticker
- Frankfurt:XUP
- Asset type
- Stock
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 10, 2026
Disclosure of the Total Number of Voting Rights and Shares Forming the Share Capital
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 18 slides
Latest news
Disclosure of the Total Number of Voting Rights and Shares Forming the Share Capital
Nov 10, 2026
Closed €11.00 (+3.2%) on Nov 10, 2026
GENFIT Highlights Data from Clinical Studies of Nangibotide, Supporting Its Advancement into ACLF with Phase 2 Data Expected in 2027
Nov 9, 2026
Closed €10.66 (-4.8%) on Nov 9, 2026
GENFIT Reports Third Quarter 2026 Financial Information and Provides Corporate Update
Nov 5, 2026
Closed €11.19 (+1.8%) on Nov 6, 2026
Information financière du troisième trimestre 2026 et point sur les activités de la Société
Nov 5, 2026
Closed €10.99 (-0.8%) on Nov 5, 2026
GENFIT to Highlight Progress in ACLF and MASH Diagnostics at AASLD The Liver Meeting® 2026
Nov 2, 2026
Closed €10.81 (-3.9%) on Nov 2, 2026
GENFIT Reports First-Half 2026 Financial Results and Provides Corporate Update
Sep 29, 2026
Closed €9.65 (-3.3%) on Sep 29, 2026
Genfit: Résultats financiers du premier semestre 2026 et point sur les activités de la Société
Sep 28, 2026
Closed €9.98 (+11.6%) on Sep 28, 2026
GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF
Sep 14, 2026
Closed €12.57 (-2.4%) on Sep 15, 2026
GENFIT engage un programme de développement clinique de phase 2 avec Nangibotide dans l’ACLF
Sep 13, 2026
Closed €12.89 (-6.2%) on Sep 14, 2026
GENFIT to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
Sep 11, 2026
Closed €13.74 (+15.1%) on Sep 11, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 18 slides · September 2026
Investor Presentation (September 2026)
Investor deck · 15 slides · September 2026
Investor Presentation (April 2026)
Investor deck · 17 slides · April 2026
Investor Presentation (April 2026)
Investor deck · 32 slides · April 2026
Genfit SA on 6ix
- News releases
- 42 in the last 12 months · 56 in all · newest Nov 10, 2026 · oldest 2025
- Decks
- 26 decks · latest September 2026
Where Genfit SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:GNFT · Home listing | Euronext | France | EUR |
| LSIN:0QT6 | LSIN | United Kingdom | EUR |
| gettex:XUP | gettex | Germany | EUR |
| Aquis:GNFTP | Aquis | United Kingdom | EUR |
| OTC:GNFTF | OTC | United States | USD |
| Munich:XUP | Munich | Germany | EUR |
| LS Exchange:A0LGJ2 | LS Exchange | Germany | EUR |
| Tradegate:XUP | Tradegate | Germany | EUR |
| Lang & Schwarz:A0LGJ2 | Lang & Schwarz | Germany | EUR |
| Xetra:XUP | Xetra | Germany | EUR |
| Frankfurt:XUP · This page | Frankfurt | Germany | EUR |
| Dusseldorf:XUP | Dusseldorf | Germany | EUR |
| Hamburg:XUP | Hamburg | Germany | EUR |
| Stuttgart:XUP | Stuttgart | Germany | EUR |
| Aquis:GNFTP | Aquis | United Kingdom | EUR |
| Turquoise:GNFTP | Turquoise | United Kingdom | EUR |
| Hanover:XUP | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Genfit SA.